Search
alpha-Tocopherol acetate
go.drugbank.com/drugs/DB14003Approved= 15 mg (22.4 IU) females = 15 mg (22.4 IU) pregnancy = 15 mg (22.4 IU) lactation = 19 mg (28.4 IU) in ages 14+ years [L2120]. … , males = 6 mg (9 IU) females = 6 mg (9 IU) in ages 1-3 years, males = 7 mg (10.4 IU) females = 7 mg (10.4 IU) in ages 4-8 years, males = 11 mg (16.4 IU) females = 11 mg (16.4 IU) in ages 9-13 years, males
Mixtures: Maxi 10 Tab, Florafol Pediatric 0.25 mg/mL Multivitamin and Fluoride Liquid DropsCategories: Compounds used in a research, industrial, or household setting, Heterocyclic Compounds, 1-RingLevothyroxine
go.drugbank.com/drugs/DB00451ApprovedInvestigationalDesiccated thyroid products contain a ratio of T4 to T3 of 4.2:1, which is significantly lower than the 14:1 ratio of secretion by the human thyroid gland. … potency of ~1:4 (T4:T3).
Synonyms: L-T4, L-ThyroxineMixtures: BITIRON 50 MCG/12.5 MCG TABLET, 100 ADET, SYNTHROID® 112 MCG TABLETASTreprostinil
go.drugbank.com/drugs/DB00374ApprovedInvestigational[L41855,L41860] The first agent approved for the treatment of PAH was [epoprostenol], a synthetic prostacyclin that significantly increases patients' quality of life. … Treprostinil was approved by the FDA in 2002 for the treatment of pulmonary arterial hypertension.
Products: TIMERAXONE ® 10 MG/ML, REMODULIN 10 mg/ml InfusionslösungFamotidine
go.drugbank.com/drugs/DB00927ApprovedInvestigationaldisease, famotidine was about 20 to 50 times more potent at inhibiting gastric acid secretion than [cimetidine] and eight times more potent than [ranitidine] on a weight basis. … [L11166] While oral formulations of famotidine are more commonly used, the intravenous solution of the drug is available for use in hospital settings.[L11142]
Synonyms: (1-Amino-3-(((2-((diaminomethylene)amino)-4-thiazolyl)methyl)thio)propylidene)sulfamideMixtures: TRIGAST 10 MG/800 MG/165 MG ÇİĞNEME TABLETİ, 12 ADET, ACİDPASS 10 MG/800 MG/165 MG ÇİĞNEME TABLETİ, 12 ADETAminophylline
go.drugbank.com/drugs/DB01223ApprovedInvestigationalAminophylline is a drug combination that contains theophylline and ethylenediamine in a 2:1 ratio. … Similar to other theophyllines, aminophylline is indicated for the treatment of lung diseases such as asthma, chronic bronchitis, and COPD.
Categories: Compounds used in a research, industrial, or household setting, Drugs for Obstructive Airway DiseasesProducts: AMINOCARDOL 10 ML 240 MG 100 AMPUL, AMINOFILINA 240 MG / 10 ML.Olmesartan
go.drugbank.com/drugs/DB00275ApprovedInvestigationalARBs selectively bind to angiotensin receptor 1 (AT1) and prevent the protein angiotensin II from binding and exerting its hypertensive effects, which include vasoconstriction, stimulation and synthesis … The angiotensin II receptor blocker (ARB) family of drugs unique in that it blocks all angiotensin II activity, regardless of where or how it was synthesized.
Synonyms: 4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid, 4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acidMixtures: Olmesartan/Amlodipin 1A Pharma 40 mg/10 mg - Filmtabletten, ILTUXAM ® 20 MG - 10 MGEtelcalcetide
go.drugbank.com/drugs/DB12865ApprovedInvestigationalEtelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. … Etelcalcetide was approved (trade name Parsabiv) for the treatment of secondary hyperparathyroidism (HPT) in adult patients with chronic kidney disease (CKD) on hemodialysis in February, 2017.
Products: PARSABIV SOLUTION FOR INJECTION 10 mg/2 mL, PARSABİV 10 MG/2 ML I.V. ENJEKSİYONLUK ÇÖZELTİ, 1 ADETZuclopenthixol
go.drugbank.com/drugs/DB01624ApprovedInvestigationalKnown drug targets of zuclopenthixol include 5-hydroxytryptamine receptor 2A, D(1B) dopamine receptor, D(2) dopamine receptor, D(1A) dopamine receptor, and alpha-1A adrenergic receptor. … Zuclopenthixol was approved for use in Canada in 2011, but is not approved for use in the United States.
Synonyms: (Z)-4-(3-(2-Chlorothioxanthen-9-ylidene)propyl)-1-piperazineethanolCategories: Adrenergic alpha-1 Receptor AntagonistsCisapride
go.drugbank.com/drugs/DB00604ApprovedWithdrawnThe FDA issued a warning letter regarding this risk to health care professionals and patients. … In many countries (including Canada) cisapride has been either withdrawn or has had its indications limited due to reports about long QT syndrome due to cisapride, which predisposes to arrhythmias.
Categories: Heterocyclic Compounds, 1-Ring, Drugs for Functional Gastrointestinal DisordersProducts: DISPEPRID 10 MG TABLET, 30 ADET, DISPEPRID 10 MG TABLET, 50 ADETClonazepam
go.drugbank.com/drugs/DB01068ApprovedIllicitInvestigational[FDA Label][A175438,A175441,L5572,F3763,F3787,F3796] Since being first patented in 1960 and then released for sale from Roche in the US in 1975,[T469,T472] clonazepam has experienced a storied history … A benzodiazepine used to treat various seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop.
Synonyms: 5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-oneProducts: RIVOTRIL 2.5 MG/1 ML DAMLA, 10 ML, RİVOCLON 2.5 MG/ 1 ML ORAL DAMLA, ÇÖZELTİ,10 ML